| Association of simple hematological parameters with disease manifestations, activity, and severity in patients with systemic sclerosis ME Yayla, U İlgen, İE Okatan, E UsluYurteri, M Torgutalp, ABK Dinçer, ... Clinical Rheumatology 39 (1), 77-83, 2020 | 37 | 2020 |
| Early onset primary Sjögren syndrome, clinical and laboratory characteristics ME Yayla, Z Karaman, M Torgutalp, AB Keleşoğlu Dinçer, ... Clinical rheumatology 39, 2689-2696, 2020 | 25 | 2020 |
| The assessment of Tp-e interval and Tp-e/QT ratio in patients with systemic sclerosis Ç Yayla, ME Yayla, KG Yayla, U Ilgen, MK Akboğa, N Düzgün Archives of rheumatology 31 (2), 139, 2016 | 20 | 2016 |
| Antiphospholipid antibodies and non-thrombotic manifestations of systemic lupus erythematosus U Ilgen, ME Yayla, A Ateş, IE Okatan, EU Yurteri, M Torgutalp, ... Lupus 27 (4), 665-669, 2018 | 19 | 2018 |
| Low serum fibroblast growth factor 2 levels not accompanied by increased serum pentraxin 3 levels in patients with systemic sclerosis U İlgen, ME Yayla, N Düzgün Clinical rheumatology 36, 367-372, 2017 | 15 | 2017 |
| Patient characteristics in Behçet’s syndrome and their associations with major organ involvement: a single-centre experience of 2118 cases M Torgutalp, DŞ Eroğlu, S Sezer, ME Yayla, G Karataş, EM Özel, ... Scandinavian Journal of Rheumatology 51 (1), 50-58, 2022 | 10 | 2022 |
| Clinical characteristics of pulmonary artery involvement in patients with Behçet’s syndrome: single-centre experience of 61 patients DS Eroglu, M Torgutalp, S Baysal, A Colaklar, S Sezer, ME Yayla, C Uzun, ... Clinical Rheumatology 40 (10), 4127-4134, 2021 | 9 | 2021 |
| Serum interleukin 35 levels in systemic sclerosis and relationship with clinical features ME Yayla, M Torgutalp, İE Okatan, EU Yurteri, O Küçükşahin, ABK Dinçer, ... JCR: Journal of Clinical Rheumatology 26 (3), 83-86, 2020 | 9 | 2020 |
| Analysis of vascular involvement in 460 patients with Behçet's syndrome: Clinical characteristics and associated factors M Torgutalp, DS Eroglu, S Sezer, ME Yayla, G Karatas, EU Yurteri, ... Joint Bone Spine 89 (2), 105277, 2022 | 8 | 2022 |
| Hidradenitis suppurativa and Mediterranean fever gene mutations U İlgen, ME Yayla, Ş Eyüpoğlu, İ Karahan JAAD Case Reports 5 (9), 792-793, 2019 | 8 | 2019 |
| Anti-angiotensin II type 1 receptor autoantibodies (AT1R-AAs) in patients with systemic sclerosis: lack of association with disease manifestations U İlgen, ME Yayla, N Düzgün Rheumatology international 37, 593-598, 2017 | 8 | 2017 |
| Can Subclinical atherosclerosis be assessed more precisely in Behçet syndrome patients by using a particular cutoff value for carotid intima media thickness? EU Yurteri, E Üstüner, M Torgutalp, ME Yayla, IE Okatan, S Sezer, ... JCR: Journal of Clinical Rheumatology 28 (1), e73-e76, 2022 | 6 | 2022 |
| An analysis of the relationship between autoantibodies andclinical findings in patients with systemic sclerosis ME Yayla, U Ilgen, N Düzgün Turkish Journal of Medical Sciences 48 (1), 10-15, 2018 | 6 | 2018 |
| AB0554 Relationship between disease activity and neutrophil-lymphocyte ratio, platelet-lymphocyte ratio and mean platelet volume in behÇet's disease IE Okatan, M Torgutalp, A Ateş, EU Yurteri, ME Yayla, ABD Keleşoğlu, ... Annals of the Rheumatic Diseases 76 (Suppl 2), 1244-1245, 2017 | 6 | 2017 |
| Causes of severe infections in patients with systemic sclerosis and associated factors ME Yayla, EU Yurteri, M Torğutalp, DŞ Eroğlu, S Sezer, ABK Dinçer, ... Turkish Journal of Medical Sciences 52 (6), 1881-1888, 2022 | 5 | 2022 |
| Serum calprotectin is indicating clinical and ultrasonographic disease activity in rheumatoid arthritis, even with normal C-reactive protein levels M Torgutalp, ME Yayla, DS Eroglu, ABK Dincer, EU Yurteri, IE Okatan, ... Mediterranean Journal of Rheumatology 32 (1), 56-65, 2021 | 5 | 2021 |
| Audiological involvement in patients with systemic sclerosis K Turan, ME Yayla, M Arslan, S Tokgoz Yilmaz, E Okatan, M Turgay, ... Modern rheumatology 32 (6), 1094-1101, 2022 | 4 | 2022 |
| Indications and risk factors for hospitalization in patients with primary Sjögren syndrome: experience from a tertiary center in Turkey ME Yayla, D Şahin Eroğlu, E Uslu Yurteri, AB Keleşoğlu Dinçer, S Sezer, ... Clinical Rheumatology, 1-7, 2022 | 4 | 2022 |
| Interstitial lung disease in systemic sclerosis: a single-center retrospective analysis ME Yayla, G Balcı, M Torgutalp, DŞ Eroğlu, ABK Dinçer, EGA Gülöksüz, ... Current Rheumatology Reviews 18 (2), 150-156, 2022 | 4 | 2022 |
| Prognostic factors for relapse and poor outcome in neuro-Behçet’s syndrome: results from a clinical long-term follow-up of a single centre D Sahin Eroglu, M Torgutalp, C Yucesan, S Sezer, ME Yayla, A Boyvat, ... Journal of Neurology, 1-9, 2022 | 3 | 2022 |
Murat TorgutalpCharité - Universitätsmedizin BerlinVerified email at charite.de
